Moderna is nearing an agreement with the US government to develop vaccines for Ebola and additional viruses considered to be threats, Bloomberg reported Wednesday. The deal is expected to see Moderna work with researchers from the University of Texas Medical Branch at Galveston to emulate its rapid approach to Covid-19 for such viruses.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,